发明名称 Reprogramming cells
摘要 The present invention provides for methods, compositions, and kits for producing an induced pluripotent stem cell from a non-pluripotent mammalian cell using a 3′-phosphoinositide-dependent kinase-1 (PDK1) activator or a compound that promotes glycolytic metabolism as well as other small molecules.
申请公布号 US9315779(B2) 申请公布日期 2016.04.19
申请号 US201313896259 申请日期 2013.05.16
申请人 The Scripps Research Institute 发明人 Zhu Saiyong;Ding Sheng
分类号 C12N5/074 主分类号 C12N5/074
代理机构 Kilpatrick Townsend & Stockton LLP 代理人 Kilpatrick Townsend & Stockton LLP
主权项 1. A method of inducing a non-pluripotent mammalian cell into an induced pluripotent stem cell, the method comprising: (a) introducing into the non-pluripotent cell a polynucleotide encoding an Oct4 polypeptide; and (b) contacting the non-pluripotent cell with a small molecule 3′-phosphoinositide-dependent kinase-1 (PDK1) activator, a TGFβ receptor/ALK5 inhibitor, and a MEK inhibitor, thereby inducing the non-pluripotent mammalian cell into an induced pluripotent stem cell.
地址 La Jolla CA US
您可能感兴趣的专利